Dosage and administration
■ Adults and children 12 years of age and over: Apply to affected area not more than 3 to 4 time daily. ■ Children under 12 years of age:consult a doctor
■ Adults and children 12 years of age and over: Apply to affected area not more than 3 to 4 time daily. ■ Children under 12 years of age:consult a doctor
Capsaicin 0.15%
Menthol 13.5%
Methyl Salicylate 30%
External Analgesic
External Analgesic
External Analgesic
For the temporary relief of minor pains and aches of muscles and joints associated with ■ simple backache ■ arthritis ■ strains
■ bruises ■sprains
■ For external use only
■ Avoid getting into the eyes or on mucous membranes.
■ do not apply to wounds or damaged skin ■ do not bandage tightly ■ do not use if excessive irritation of the skin develops
■ do not use otherwise than as directed
■ condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days ■ pain persists for more than 10 days ■ redness is present ■ conditions affect children under 12 years of age.
to avoid accidental poisoning. In case of accidental ingestion, contact a doctor or Poison Control Center Immediately
■ Adults and children 12 years of age and over: Apply to affected area not more than 3 to 4 time daily.
■ Children under 12 years of age:consult a doctor
eucalyptol, fragrance, paraffin wax and petroleum jelly
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1045385 | capsaicin 0.15 % / menthol 13.5 % / methyl salicylate 30 % Topical Ointment | PSN | 5 |
| 1045385 | capsaicin 0.0015 MG/MG / menthol 0.135 MG/MG / methyl salicylate 0.3 MG/MG Topical Ointment | SCD | 5 |
| 1045385 | capsaicin 0.15 % / menthol 13.5 % / methyl salicylate 30 % Topical Ointment | SY | 5 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 473d070d-1c38-488e-b991-c4d1bf45aab8 | Product name | 1 | 20210201 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43405-007-01 | Muscular Balm | 1 in 1 BOX | OINTMENT | 1 | 5 | |
| 43405-007-20 | Muscular Balm | 20 g in 1 JAR | OINTMENT | 20 | 5 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Capsaicin | ACTIVE INGREDIENT | S07O44R1ZM | 2 | |
| Menthol | ACTIVE INGREDIENT | L7T10EIP3A | 2 | |
| Methyl Salicylate | ACTIVE INGREDIENT | LAV5U5022Y | 2 | |
| Capsaicin | ACTIVE MOIETY | S07O44R1ZM | 2 | |
| Menthol | ACTIVE MOIETY | L7T10EIP3A | 2 | |
| Methyl Salicylate | ACTIVE MOIETY | LAV5U5022Y | 2 | |
| Eucalyptol | INACTIVE INGREDIENT | RV6J6604TK | 2 | |
| Paraffin | INACTIVE INGREDIENT | I9O0E3H2ZE | 2 | |
| Petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43405-007 | 43405-007-20, 43405-007-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| EUCALYPTOL | RV6J6604TK | IACT |
| PARAFFIN | I9O0E3H2ZE | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
| CAPSAICIN | S07O44R1ZM | ACTIB |
| MENTHOL | L7T10EIP3A | ACTIB |
| METHYL SALICYLATE | LAV5U5022Y | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Eucalyptol | EUCALYPTOL | RV6J6604TK | DROPS / NASAL | 0.2 mg/1ml | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | SOLUTION / NASAL | 0.2 mg/1ml | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | CAPSULE / ORAL | NA | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | DROPS / OPHTHALMIC | 0.02 %w/w | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | SOLUTION / NASAL | 0.2 mg/1ml | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | DROPS / NASAL | 0.2 mg/1ml | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | SOLUTION / NASAL | 0.2 mg/1ml | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | CAPSULE / ORAL | NA | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| Paraffin | PARAFFIN | I9O0E3H2ZE | OINTMENT / TOPICAL | 2860 mg | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | PASTE, DENTIFRICE / DENTAL | 2.4 %w/w | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | SOLUTION / DENTAL | NA | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | SOLUTION / DENTAL | NA | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | PASTE, DENTIFRICE / DENTAL | 2.4 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | JELLY / NASAL | 68.5 mg | ||
| Paraffin | PARAFFIN | I9O0E3H2ZE | OINTMENT / TOPICAL | 2860 mg | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | DROPS / OPHTHALMIC | 0.02 %w/w | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | DROPS / OPHTHALMIC | 0.02 %w/w | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | JELLY / NASAL | 68.5 mg | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | CAPSULE / ORAL | NA | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | PASTE, DENTIFRICE / DENTAL | 2.4 %w/w | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | DROPS / NASAL | 0.2 mg/1ml | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | JELLY / NASAL | 68.5 mg | ||
| Paraffin | PARAFFIN | I9O0E3H2ZE | OINTMENT / TOPICAL | 2860 mg | ||
| Eucalyptol | EUCALYPTOL | RV6J6604TK | SOLUTION / DENTAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Muscular Balm | CAPSAICIN MENTHOL METHYL SALICYLATE | Borden Company (Private) Limited | ed79f14e-6b3d-4bf2-9c34-d019c1ba2582 | 2024-11-04 | Warnings | 43405-007-20 43405-007-01 43405-007 43405000701 43405000720 2621e308-8117-7240-e063-6294a90a44ea ed79f14e-6b3d-4bf2-9c34-d019c1ba2582 |
Adverse event summaries are temporarily unavailable. Other product information remains available.